Comparative effectiveness and safety of ribavirin plus interferonalpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

相关推荐

• Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin
• Clinical Study of Mild Moxibustion plus Cupping in Treating Sports Fatigue
• 脸Plus
• CLINICAL STUDY ON TREATMENT OF SENILE STROKE PATIENTS BY ACUPUNCTURE PLUS CHINESE MEDICINAL HERBS
• Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

同分类资源 更多

• [医药卫生] 宫颈癌2018与2009 FIGO分期的比较及预后因素分析
• [医药卫生] 喜炎平注射液预防放射性食管炎的疗效分析
• [医药卫生] 阿帕替尼联合化疗在晚期非小细胞肺癌患者中的临床疗效和最佳剂量探讨
• [医药卫生] 安罗替尼联合化疗对二线化疗失败晚期非小细胞肺癌的疗效分析
• [医药卫生] 沉默PSIP1基因对口腔鳞状细胞癌细胞迁移及侵袭的影响

相关关键词